South San Francisco, CA
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. They aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HPV.
antivabio.comThese are collections Antiva Biosciences is a part of. Click on the collection name to view similar companies.
Series E
$53,000,000
Series D
$31,000,000
Series C
$15,000,000
Series C
$22,000,000
Series B
$16,000,000
Series Unknown
$1,745,019
Debt Financing
$1,100,000
Series Unknown
$1,126,006
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Antiva Biosciences.